Melphalan 200 mg/m2 versus Melphalan 100 mg/m2 in newly diagnosed myeloma patients: a prospective, multi-center phase III study

Autor:	Palumbo, A, Bringhen, S, Bruno, B, Falcone, Ap, Liberati, Am, Grasso, M, Ria, R, Pisani, F, Cangialosi, C, Caravita, T, Levi, A, Meloni, Giovanna, Nozza, A, Pregno, P, Gabbas, A, Callea, V, Rizzo, M, Annino, L, DE STEFANO, V, Musto, P, Baldi, I, Cavallo, F, Petrucci, Mt, Massaia, M, Boccadoro, M.
Jazyk:	angličtina
Rok vydání:	2010
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3686::dc7790c99dc3b5a79b9dec56af71fc1f http://hdl.handle.net/11573/89751 Zobrazit plný text záznamu